{"entity":{"id":"uppsala-akademiska","kind":"institution","name":"Uppsala University Hospital / Uppsala University","aka":["Akademiska sjukhuset","Skandion Clinic","Rudbeck Laboratory"],"tldr":"Uppsala University Hospital is Sweden's oldest; its neuroendocrine tumour centre built by Kjell Öberg is an ENETS Centre of Excellence with long experience of somatostatin analogues and radionuclide therapy, and Sweden's national Skandion proton clinic opened next door in 2015.","summary":"Akademiska sjukhuset and Uppsala University form one of Scandinavia's leading cancer research environments. Uppsala's neuroendocrine tumour centre, built by Kjell Öberg, is an ENETS Centre of Excellence with long experience of somatostatin analogues and peptide receptor radionuclide therapy, and Bengt Glimelius's group shaped Nordic rectal cancer radiotherapy trials. The Skandion Clinic, Sweden's national proton therapy facility co-owned by the university regions, opened in Uppsala in 2015 using IBA equipment. Tobias Sjöblom's laboratory contributed to the first colorectal cancer exome sequencing and runs the U-CAN biobank, Uppsala scientists founded Olink Proteomics, and the Uppsala Clinical Research Center supports national trials.","asOf":"2026-09-09","links":[{"label":"Homepage","url":"https://www.akademiska.se"},{"label":"Skandion Clinic","url":"https://www.skandionkliniken.se"}],"tags":[],"related":[],"cancers":["neuroendocrine","colorectal","prostate","glioblastoma"],"sections":["radiopharma","radiation"],"technologies":["proton-therapy","radioligand-therapy","proteomics","wes-wgs"],"targets":["sstr2"],"drugs":["lutathera"],"companies":["iba"],"institutions":["karolinska"],"pathways":[],"terms":[],"trials":[],"people":["marianne-van-rooijen"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Uppsala","country":"SE","lat":59.849,"lng":17.637,"institutionType":"hospital","website":"https://www.akademiska.se","university":"Uppsala University","programs":["Neuroendocrine tumour centre","Skandion proton clinic","Gastrointestinal radiotherapy trials","U-CAN biobank","Proteomics"]},"route":"/institutions/uppsala-akademiska/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"},{"id":"neuroendocrine","kind":"cancer","name":"Neuroendocrine tumours","route":"/cancers/neuroendocrine/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"section":[{"id":"radiation","kind":"section","name":"Radiation Therapy","route":"/fronts/radiation/"},{"id":"radiopharma","kind":"section","name":"Radiopharmaceuticals & Theranostics","route":"/fronts/radiopharma/"}],"technology":[{"id":"proteomics","kind":"technology","name":"Proteomics & phosphoproteomics","route":"/technologies/proteomics/"},{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"radioligand-therapy","kind":"technology","name":"Radioligand therapy (beta emitters)","route":"/technologies/radioligand-therapy/"},{"id":"wes-wgs","kind":"technology","name":"Whole-exome & whole-genome sequencing","route":"/technologies/wes-wgs/"}],"target":[{"id":"sstr2","kind":"target","name":"Somatostatin receptor 2","route":"/targets/sstr2/"}],"drug":[{"id":"lutathera","kind":"drug","name":"Lutetium-177 dotatate","route":"/drugs/lutathera/"}],"company":[{"id":"iba","kind":"company","name":"IBA (Ion Beam Applications)","route":"/companies/iba/"}],"institution":[{"id":"karolinska","kind":"institution","name":"Karolinska University Hospital","route":"/institutions/karolinska/"},{"id":"linkoping-university-hospital","kind":"institution","name":"Linköping University Hospital Cancer Center","route":"/institutions/linkoping-university-hospital/"}],"person":[{"id":"marianne-van-rooijen","kind":"person","name":"Marianne van Rooijen","route":"/people/marianne-van-rooijen/"}]}}